MedPath

Comparison the effect of intranasal midazolam versus different doses of intranasal ketamine in reducing preoperative pediatric anxiety

Phase 2
Conditions
Behavioural and emotional disorders with onset usually occurring in childhood and adolescence.
Phobic anxiety disorder of childhood
Registration Number
IRCT201104236254N1
Lead Sponsor
Vice-chancellor for research of Qazvin University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Elective surgery ;ASA class 1; Age between 2-8 years Exclusion criteria : ASA class 2 or higher ;Children using antihistaminic, anticonvulsive ,analgesic or sedative agents ;Children with nasopharyngeal disorder, upper respiratory tract infection ,epistaxis or allergic rhinitis.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Fftheen minutes after drug usage(before IV line insertion). Method of measurement: M-Yale PAS.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath